QUIDELORTHO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.82 USD | +1.04% |
|
+5.45% | -44.61% |
| Apr. 02 | QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay | MT |
| Apr. 02 | QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test | MT |
Chart calendar QuidelOrtho Corporation
111f523d2bb8cf4f94ce93.VYUOTyKLpTEb6_8JUGUuoZHi1u8FeahKEQbM2BSQ664.ELc4NWG7_AEtpKxAZwZX1OK6srV2PMQieFW1sXjlqOwH8mkNW-PqBiqkrg~a9da85008dffcaadaf03b2f2fe8178f6
Upcoming events on QuidelOrtho Corporation
Past events on QuidelOrtho Corporation
| 2024-03-05 04:00 pm | Raymond James Institutional Investors Conference |
| 2024-02-13 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-13 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-08 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-30 09:10 am | Evercore ISI HealthCONx Conference |
| 2023-11-01 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-01 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-12 02:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-08 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-08 04:30 pm | Q2 2023 Earnings Release |
| 2023-06-06 03:00 pm | William Blair Growth Stock Conference |
| 2023-05-16 11:30 am | Annual General Meeting |
| 2023-05-03 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-03 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-07 11:35 am | Raymond James Institutional Investors Conference |
| 2023-02-15 05:00 pm | FY 2022 Earnings Call |
| 2023-02-15 04:05 pm | FY 2022 Earnings Release |
| 2023-01-09 12:00 pm | JP Morgan Healthcare Conference |
| 2022-12-13 01:00 pm | Investor Day |
| 2022-11-02 05:00 pm | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 535 531 0.76% | 1 662 1 663 -0.08% | 1 699 1 579 7.56% | 3 266 3 548 -7.96% | 2 998 3 043 -1.48% | 2 798 |
|
EBITDA Million USD | Released Forecast Spread | 156 162 -3.33% | 1 109 1 084 2.31% | 996 913 9.11% | 1 331 1 381 -3.63% | 723 804 -10.03% | 600 |
|
EBIT Million USD | Released Forecast Spread | 92,7 92,4 0.34% | 1 060 1 004 5.56% | 906 823 10.04% | 844 1 072 -21.28% | 139 591 -76.47% | 307 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 77,2 78,4 -1.5% | 1 040 968 7.47% | 900 818 10.04% | 736 766 -3.93% | -29,1 91,9 -131.68% | -117 |
|
Net income Million USD | Released Forecast Spread | 72,9 69,4 5.07% | 810 769 5.38% | 704 644 9.34% | 549 543 1.06% | -10,1 71,3 -114.17% | -72,2 |
|
EPS USD | Released Forecast Spread | 1,73 1,59 8.58% | 18,6 17,7 4.91% | 16,4 15,0 9.31% | 9,56 9,34 2.33% | -0,15 1,07 -114.07% | -1,08 |
| Announcement Date | 12/02/20 | 18/02/21 | 17/02/22 | 15/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 637 517 23.1% | 1 002 865 15.86% | 613 708 -13.41% | 784 720 8.92% | 867 776 11.69% | 846 772 9.58% | 665 615 8.22% | 744 692 7.47% | 743 787 -5.7% | 699 | 646 | 679 | 774 | 705 |
|
EBITDA Million USD | Released Forecast Spread | 406 320 26.81% | 648 498 30.15% | 218 255 -14.58% | 227 162 39.98% | 245 220 11.27% | 245 218 12.45% | 113 114 -0.41% | 169 147 15.21% | 195 276 -29.2% | 151 | 101 | 136 | 210 | 176 |
|
EBIT Million USD | Released Forecast Spread | 377 294 28.1% | 621 518 19.75% | 79,7 137 -41.74% | 56,8 48,7 16.52% | 86,5 139 -37.97% | 131 163 -19.49% | 60,1 63,9 -5.98% | 26,3 92,7 -71.64% | 40,1 219 -81.72% | 78,7 | 26,6 | 64,3 | 138 | 89,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 375 293 27.99% | 621 518 19.93% | 42,9 119 -64.04% | 31,3 16,4 90.53% | 41,1 71,0 -42.11% | 60,0 75,6 -20.58% | -64,4 -44,1 -46.01% | -15,5 -29,8 47.99% | -9,20 112 -108.23% | -35,3 | -97,0 | -42,9 | 38,5 | 8,88 |
|
Net income Million USD | Released Forecast Spread | 291 231 26.02% | 480 409 17.44% | 19,3 94,4 -79.56% | 19,2 11,8 62.03% | 30,3 55,0 -44.93% | 48,8 57,3 -14.82% | -53,2 -24,9 -113.59% | -12,7 -14,3 10.94% | 7,00 91,4 -92.34% | -27,1 | -73,5 | -32,2 | 29,3 | 6,41 |
|
EPS USD | Released Forecast Spread | 6,85 5,39 27.01% | 11,3 8,94 26.51% | 0,36 1,91 -81.14% | 0,28 0,31 -10.2% | 0,45 0,74 -38.95% | 0,73 0,80 -9.17% | -0,80 -0,38 -110.1% | -0,19 -0,25 22.87% | 0,10 1,32 -92.42% | -0,41 | -0,99 | -0,49 | 0,43 | 0,10 |
| Announcement Date | 17/02/22 | 04/05/22 | 04/08/22 | 02/11/22 | 15/02/23 | 03/05/23 | 08/08/23 | 01/11/23 | 13/02/24 | - | - | - | - | - |
| 2024-04-28 | INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | CONTEC MEDICAL SYSTEMS CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-28 | INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-02 04:05 pm | VAREX IMAGING CORPORATION: Q2 2024 Earnings Release |
| 2024-05-07 | QUIDELORTHO CORPORATION: Q1 2024 Earnings Release |
| 2024-07-15 | BIOTAGE AB: Q2 2024 Earnings Release |
| 2024-07-19 01:00 am | SARTORIUS AG: Q2 2024 Earnings Release |
| 2024-07-29 | VAREX IMAGING CORPORATION: Q3 2024 Earnings Release (Projected) |
| 2024-07-31 | QUIDELORTHO CORPORATION: Q2 2024 Earnings Release (Projected) |
| 2024-08-07 | REVENIO GROUP OYJ: Q2 2024 Earnings Release |
Past sector events for QuidelOrtho Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QDEL Stock
- Calendar QuidelOrtho Corporation
